"PBMs"

Trenton, NJ – A federal judge has denied consumers’ request to reconsider part of a ruling that trimmed their sweeping challenge to the alleged insulin pricing scheme led by Novo …

TRENTON, NJ — A new bill introduced in the New Jersey Senate aims to set minimum reimbursement rates for pharmacies serving Medicaid patients and ensure patients can access prescription drugs …

The criminal complaint alleges that undercover agents from the Lea County Drug Task Force purchased two Glock switches and one silencer from Tevon Wayne Davis Cobbs, 22, in the parking …

According to court documents, a federal search warrant was executed on April 9, 2024, at two residences – one in Orlando and one in Ocoee – used by Pherai-Bogeajis. At …

By Steve Holland and Nandita Bose WASHINGTON (Reuters) -President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription …

PHILADELPHIA, PA – District Attorney Larry Krasner announced on Monday a significant legal move against nearly 20 pharmaceutical companies and pharmacy benefit managers (PBMs) for allegedly colluding to inflate the …

By Ahmed Aboulenein WASHINGTON (Reuters) – U.S. Senate Democrats grilled three top pharmaceutical executives over the high cost of prescription drugs on Thursday but failed to extract any commitments from …

By Jonathan Stempel and Brendan Pierson (Reuters) -Eli Lilly agreed to provide low-cost insulin to patients and donate free insulin to clinics, to settle a lawsuit by Minnesota that accused …

By Christy Santhosh (Reuters) -Tyson Foods has dropped CVS Health as its pharmacy benefit manager and replaced it with Rightway, the startup said on Wednesday, to manage drug benefits for …

By Dietrich Knauth NEW YORK (Reuters) – Pharmacy chain Rite Aid Corp on Tuesday received bankruptcy court approval to sell its Elixir pharmacy benefit manager business for $575 million. Rite …

By Patrick Wingrove and Manas Mishra (Reuters) -Eli Lilly on Tuesday said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies and could cost $550 a month …

By Leroy Leo and Mariam Sunny (Reuters) -CVS Health on Tuesday forecast 2024 revenue above market estimates and said it would simplify the structure through which its pharmacies get reimbursed …

By Anirban Sen and Deena Beasley (Reuters) -U.S. health insurer Cigna is in talks to merge with peer Humana, a source familiar with the matter said on Wednesday, a deal …

By Leroy Leo and Mariam Sunny (Reuters) -CVS Health Corp tempered its forecast for 2024 earnings on Wednesday to account for potentially higher medical costs at its insurance unit as …

By Bhanvi Satija and Patrick Wingrove (Reuters) -Blue Shield of California plans to stop using most of CVS Health’s pharmacy benefit management services and work with others, including Amazon.com and …

By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Thursday trimmed its 2023 view for declining sales of its flagship arthritis drug Humira despite new competition, as favorable positions on …

By Patrick Wingrove (Reuters) – Cheaper versions of one of the most costly and widely used arthritis treatments in the U.S. are likely to fuel further scrutiny of the middlemen …

(Reuters) -The U.S. Federal Trade Commission said it had sought information from two privately held companies that negotiate drug rebates on behalf of pharmacy benefit managers (PBMs) as part of …

By Ahmed Aboulenein WASHINGTON (Reuters) – Leaders of major insulin makers and pharmacy benefit managers (PBMs) traded blame for the life-saving drug’s high price on Wednesday while testifying at a …

By Bhanvi Satija and Raghav Mahobe (Reuters) – CVS Health Corp will buy Oak Street Health Inc for about $9.5 billion in cash, joining rivals in adding primary care to …

By Leroy Leo (Reuters) -Cigna Corp expects its pharmacy benefit management unit to earn more from the second half of 2023 as makers of cheaper versions of AbbVie Inc’s arthritis …

By Patrick Wingrove (Reuters) – U.S. patients will finally get access to cheaper versions of AbbVie Inc’s blockbuster arthritis drug Humira this year, but the cost savings are expected to …